|
1
|
Dorsey ER, Constantinescu R, Thompson JP,
et al: Projected number of people with Parkinson's disease in the
most populous nations, 2005 through 2030. Neurology. 68:384–386.
2007. View Article : Google Scholar
|
|
2
|
Mori F, Nishie M, Kakita A, Yoshimoto M,
Takahashi H and Wakabayashi K: Relationship among alpha-synuclein
accumulation, dopamine synthesis, and neurodegeneration in
Parkinson disease substantia nigra. J Neuropathol Exp Neurol.
65:808–815. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Croisier E, Moran LB, Dexter DT, Pearce RK
and Graeber MB: Microglial inflammation in the parkinsonian
substantia nigra: Relationship to alphaa-synuclein deposition. J
Neuroinflammation. 2:142005. View Article : Google Scholar
|
|
4
|
Stevens CH, Rowe D, Morel-Kopp MC, Orr C,
Russell T, Ranola M, Ward C and Halliday GM: Reduced T helper and B
lymphocytes in Parkinson's disease. J Neuroimmunol. 252:95–99.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Umemura A, Oeda T, Tomita S, Hayashi R,
Kohsaka M, Park K, Sugiyama H and Sawada H: Delirium and high Fever
are associated with subacute motor deterioration in Parkinson
disease: A nested case-control study. PLOS One. 9:e949442014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noelker C, Morel L, Osterloh A,
Alvarez-Fischer D, Lescot T, Breloer M, Gold M, Oertel WH, Henze C,
Michel PP, et al: Heat shock protein 60: An endogenous inducer of
dopaminergic cell death in Parkinson disease. J Neuroinflammation.
11:862014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
More SV, Kumar H, Kim IS, Song SY and Choi
DK: Cellular and molecular mediators of neuroinflammation in the
pathogenesis of Parkinson's disease. Mediators Inflamm.
2013:9523752013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bakay RA, Boyer KL, Freed CR and Ansari
AA: Immunological responses to injury and grafting in the central
nervous system of nonhuman primates. Cell Transplant. 7:109–120.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luk KC, Kehm VM, Zhang B, O'Brien P,
Trojanowski JQ and Lee VM: Intracerebral inoculation of
pathological α-synuclein initiates a rapidly progressive
neurodegenerative α-synucleinopathy in mice. J Exp Med.
209:975–986. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maetzler W, Apel A, Langkamp M, Deuschle
C, Dilger SS, Stirnkorb JG, Schulte C, Schleicher E, Gasser T and
Berg D: Comparable autoantibody serum levels against amyloid- and
inflammation-associated proteins in Parkinson's disease patients
and controls. PLOS One. 9:e886042014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamza TH, Zabetian CP, Tenesa A, Laederach
A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E,
et al: Common genetic variation in the HLA region is associated
with late-onset sporadic Parkinson's disease. Nat Genet.
42:781–785. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Melief J, Koning N, Schuurman KG, Van De
Garde MD, Smolders J, Hoek RM, Van Eijk M, Hamann J and Huitinga I:
Phenotyping primary human microglia: Tight regulation of LPS
responsiveness. Glia. 60:1506–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shannon KM, Keshavarzian A, Dodiya HB,
Jakate S and Kordower JH: Is alpha-synuclein in the colon a
biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Mov Disord. 27:716–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirsch EC and Hunot S: Neuroinflammation
in Parkinson's disease: A target for neuroprotection? Lancet
Neurol. 8:382–397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brochard V, Combadière B, Prigent A,
Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer
D, Callebert J, Launay JM, et al: Infiltration of CD4+lymphocytes
into the brain contributes to neurodegeneration in a mouse model of
Parkinson disease. J Clin Invest. 119:182–192. 2009.
|
|
16
|
González H, Contreras F, Prado C, Elgueta
D, Franz D, Bernales S and Pacheco R: Dopamine receptor D3
expressed on CD4+ T cells favors neurodegeneration of dopaminergic
neurons during Parkinson's disease. J Immunol. 190:5048–5056. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou L, Chong MM and Littman DR:
Plasticity of CD4+ T cell lineage differentiation. Immunity.
30:646–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wan YY: Multi-tasking of helper T cells.
Immunology. 130:166–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mu L, Sun B, Kong Q, Wang J, Wang G, Zhang
S, Wang D, Liu Y, Liu Y, An H, et al: Disequilibrium of T helper
type 1, 2 and 17 cells and regulatory T cells during the
development of experimental autoimmune myasthenia gravis.
Immunology. 128:e826–e836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nie K, Zhang Y, Gan R and Wang L, Zhao J,
Huang Z, Tang H and Wang L: Polymorphisms in immune/inflammatory
cytokine genes are related to Parkinson's disease with cognitive
impairment in the han chinese population. Neurosci Lett.
541:111–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sanchez-Guajardo V, Annibali A, Jensen PH
and Romero-Ramos M: α-Synuclein vaccination prevents the
accumulation of parkinson disease-like pathologic inclusions in
striatum in association with regulatory T cell recruitment in a rat
model. J Neuropathol Exp Neurol. 72:624–645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saunders JA, Estes KA, Kosloski LM, Allen
HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni
JM, Murman DL, et al: CD4+ regulatory and effector/memory T cell
subsets profile motor dysfunction in Parkinson's disease. J
Neuroimmune Pharmacol. 7:927–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niwa F, Kuriyama N, Nakagawa M and
Imanishi J: Effects of peripheral lymphocyte subpopulations and the
clinical correlation with Parkinson's disease. Geriatr Gerontol
Int. 12:102–107. 2012. View Article : Google Scholar
|
|
24
|
Fazekas de St Groth B, Zhu E, Asad S and
Lee L: Flow cytometric detection of human regulatory T cells.
Methods Mol Biol. 707:263–279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McClymont SA, Putnam AL, Lee MR, Esensten
JH, Liu W, Hulme MA, Hoffmüller U, Baron U, Olek S, Bluestone JA,
et al: Plasticity of human regulatory T cells in healthy subjects
and patients with type 1 diabetes. J Immunol. 186:3918–3926. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pott Godoy MC, Ferrari CC and Pitossi FJ:
Nigral neurode-generation triggered by striatal AdIL-1
administration can be exacerbated by systemic IL-1 expression. J
Neuroimmunol. 222:29–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hasegawa Y, Inagaki T, Sawada M and
Suzumura A: Impaired cytokine production by peripheral blood
mononuclear cells and monocytes/macrophages in Parkinson's disease.
Acta Neurol Scand. 101:159–164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brodacki B, Staszewski J, Toczyłowska B,
Kozłowska E, Drela N, Chalimoniuk M and Stepien A: Serum
interleukin (IL-2, IL-10, IL-6, IL-4), TNF alpha and INF gamma
concentrations are elevated in patients with atypical and
idiopathic parkinsonism. Neurosci Lett. 441:158–162. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reale M, Iarlori C, Thomas A, Gambi D,
Perfetti B, Di Nicola M and Onofrj M: Peripheral cytokines profile
in Parkinson's disease. Brain Behav Immun. 23:55–63. 2009.
View Article : Google Scholar
|
|
30
|
Mu L, Sun B, Kong Q, Wang J, Wang G, Zhang
S, Wang D, Liu Y, Liu Y, An H, et al: Disequilibrium of T helper
type 1, 2 and 17 cells and regulatory T cells during the
development of experimental autoimmune myasthenia gravis.
Immunology. 128(1 Suppl): e826–e836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hawkins RD, Larjo A, Tripathi SK, Wagner
U, Luu Y, Lönnberg T, Raghav SK, Lee LK, Lund R, Ren B, Lähdesmäki
H and Lahesmaa R: Global chromatin state analysis reveals
lineage-specific enhancers during the initiation of human T helper
1 and T helper 2 cell polarization. Immunity. 38:1271–1284. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olson NC, Sallam R, Doyle MF, Tracy RP and
Huber SA: T helper cell polarization in healthy people:
Implications for cardiovascular disease. J Cardiovasc Transl Res.
6:772–786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wan YY and Flavell RA: How diverse - CD4
effector T cells and their functions. J Mol Cell Biol. 1:20–36.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Homey B: After TH1/TH2 now comes
Treg/TH17: Significance of T helper cells in immune response
organization. Hautarzt. 57:730–732. 2006.In German. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sakaguchi S, Ono M, Setoguchi R, Yagi H,
Hori S, Fehervari Z, Shimizu J, Takahashi T and Nomura T: Foxp3+
CD25+ CD4+ natural regulatory T cells in dominant self-tolerance
and autoimmune disease. Immunol Rev. 212:8–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Z, Lin F, Gao Y, Li Z, Zhang J, Xing
Y, Deng Z, Yao Z, Tsun A and Li B: FOXP3 and RORγt: Transcriptional
regulation of Treg and Th17. Int Immunopharmacol. 11:536–542. 2011.
View Article : Google Scholar
|
|
37
|
Charles PD, Esper GJ and Davis TL: A
definition of “on”: Patient diaries compared to the UPDRS.
Parkinsonism Relat Disord. 5:99–101. 1999. View Article : Google Scholar
|
|
38
|
Longhi M, Ricciardi G, Tommasi G, Nicolato
A, Foroni R, Betrolasi L, Beltramello A, Moretto G, Tinazzi M and
Gerosa M: The role of 3T magnetic resonance imaging for targeting
the human subthalamic nucleus in deep brain stimulation for
Parkinson Disease. J Neurol Surg A Cent Eur Neurosurg. 76:181–189.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Braak H, Sastre M, Bohl JR, de Vos RA and
Del Tredici K: Parkinson's disease: Lesions in dorsal horn layer I,
involvement of parasympathetic and sympathetic pre- and
postganglionic neurons. Acta Neuropathol. 113:421–429. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Yu M, Liu X, Qu H, Chen Q, Qian W,
Wei D, Xu W, Ma B and Wu W: Clinical characteristics and peripheral
T cell subsets in Parkinson's disease patients with constipation.
Int J Clin Exp Pathol. 8:2495–2504. 2015.PubMed/NCBI
|
|
41
|
Reynolds AD, Stone DK, Hutter JA, Benner
EJ, Mosley RL and Gendelman HE: Regulatory T cells attenuate Th17
cell-mediated nigrostriatal dopaminergic neurodegeneration in a
model of Parkinson's disease. J Immunol. 184:2261–2271. PubMed/NCBI
|
|
42
|
Appel SH: CD4+ T cells mediate
cytotoxicity in neurodegenerative diseases. J Clin Invest.
119:13–15. 2009.
|
